Pharma Co. Teligent Opens Ch. 11 In Del. With $130M Debt
Generic pharmaceutical company Teligent Inc. sought Chapter 11 protection in Delaware on Thursday with nearly $130 million in debt and plans for a sale, saying it has been dealing with "regulatory...To view the full article, register now.
Already a subscriber? Click here to view full article